Could squeezing a ball make port needle changes less painful?
NCT ID NCT07679295
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study investigates whether using a stress ball during port catheter needle changes can reduce pain, anxiety, and improve satisfaction in cancer patients. Fifty adult oncology patients will be randomly assigned to either use a stress ball or receive standard care. The goal is to find a simple, drug-free way to make this common procedure more comfortable.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- stress ball
- What this could lead to
- If it works, this simple, low-cost technique could help cancer patients feel less pain and anxiety during port needle changes.
- What could go wrong
- This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The stress ball may not significantly reduce pain or anxiety for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being over 18 years of age, * Receiving treatment and care in the oncology ward, * Having the hand function to physically use a stress ball, * Patients who volunteer to participate in the study will be included. Exclusion Criteria: * Patients who cannot be communicated with, * Those with peripheral neuropathic complaints, * Those with psychiatric diagnoses, * Patients who refuse to participate in the study will not be included.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Vascular access are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Şanlıurfa Mehmet Akif İnan Education and Research Hospital
Sanliurfa, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can fewer dressing changes make PICC lines safer?
- A simple ultrasound might replace invasive pressure monitoring
- Lab-Grown vessels could revolutionize dialysis access
- Dialysis dilemma: catheter or fistula for the elderly?
- New catheter coating could cut dialysis complications
- One needle to rule them all: new dialysis device aims to simplify treatment